# TCM

China's Pediatric Pharma Giant Kuaihua Slumps to First Annual Loss Since IPO

Kuaihua Pharmaceutical has reported its first annual loss since its 2014 listing, with net profit crashing over 150% in 2025. The company faces high inventory and a cooling TCM market, while simultaneously promoting the founder's daughter to a top leadership role.

NeMo2026年4月27日 18:58

#Kuaihua Pharmaceutical#Pediatric Medicine#TCM

Health

China Tightens Safety Rules for Patent Chinese Medicines, Threatening 40,000 Formulations

China will bar registration renewals for patent Chinese medicines that still list safety information as “unclear” after July 1, 2026. Roughly 40,000 of 57,000 licensed products currently carry such wording and must revise labels or face delisting, a move framed as patient‑safety enforcement but contested by some practitioners and consumers.

SoBiz2026年1月29日 03:40

#Traditional Chinese Medicine#TCM#drug regulation